Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
isabgol + lactulose
- Development stage
- Unknown
- Lead developer
- Ibn Sina Pharmaceuticals
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Administration
- Oral
01
Overview
Isabgol + lactulose is a fixed-dose combination of two laxatives used primarily for the treatment of chronic idiopathic constipation and to maintain regular bowel function in patients prone to constipation[1][2][3]. Isabgol (also known as ispaghula or psyllium husk) acts as a bulk-forming laxative by absorbing water in the intestine to increase stool bulk and promote peristalsis. Lactulose is an osmotic laxative that draws water into the colon and acidifies colonic contents through bacterial fermentation; this softens stools and stimulates bowel movements. The combination provides both immediate osmotic action (from lactulose) and longer-term regulation of bowel habits (from isabgol), making it useful for chronic constipation management[1][2][3]. It may also be used in cases associated with irritable bowel syndrome. Common side effects include flatulence and abdominal discomfort.
- Brand names
- Evict FibreLivoluk FibreOsilaxCachlaxLactilaxFiber ForteIsablacFiberfosLactizSensegood
- Other names
- ispaghula + lactuloseispaghula husk + lactulose
Beyond the preview
Go deeper on isabgol + lactulose.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on isabgol + lactulose.